Nelfinavir clinical trials
Also written Viracept and AG1343.
How each study uses Nelfinavir is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the Nelfinavir studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- 14 Mar 1997 · VIRACEPT · NDA 020778 (FDA, Drugs@FDA)
- European Union
- 22 Jan 1998 · Viracept · EMEA/H/C/000164 (EMA; now withdrawn)
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
57 studies that test it; most in 2009 (6)
| Year | Studies |
|---|---|
| 1997 | 3 |
| 1999 | 5 |
| 2000 | 4 |
| 2001 | 1 |
| 2002 | 1 |
| 2003 | 3 |
| 2004 | 1 |
| 2005 | 2 |
| 2006 | 5 |
| 2007 | 2 |
| 2008 | 2 |
| 2009 | 6 |
| 2010 | 2 |
| 2012 | 3 |
| 2013 | 1 |
| 2014 | 5 |
| 2015 | 1 |
| 2016 | 1 |
| 2017 | 2 |
| 2018 | 2 |
| 2019 | 1 |
| 2020 | 1 |
| 2022 | 1 |
| 2025 | 2 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 30 · Other 52
National Institute of Allergy and Infectious Diseases (NIAID) (11) · Agouron Pharmaceuticals (9) · Abramson Cancer Center at Penn Medicine (6) · Glaxo Wellcome (5) · Mayo Clinic (3) · University of Iowa (3) · Swiss Group for Clinical Cancer Research (3) · Bristol-Myers Squibb (3)
Often tested with
Tested in the same studies.
Efavirenz (9) · Lamivudine (9) · Saquinavir (7) · Zidovudine (7) · Ritonavir (6) · Indinavir (6) · Stavudine (6) · Cisplatin (4)
Related medicines
As reviewed, each with the page that says it.
- One of Protease Inhibitors source
Coming up
From the study records. Dates are the sponsors’ own estimates and often move.
Reaching primary completion within a year · 3
Studies that test Nelfinavir.
- Dec 2026Nelfinavir, Cisplatin, and External Beam Radiation Therapy for the Treatment of Locally Advanced Vulvar Cancer That Cannot Be Removed by SurgeryPhase 1 · M.D. Anderson Cancer Center
- May 2027COAST Therapy in Advanced Solid Tumors and Prostate CancerPhase 1/2 · Medical University of South Carolina
- Jun 2027Treating Anemia in Myelofibrosis With Repurposed Drugs (Nelfinavir) That Restore Iron Delivery to the Bone MarrowPhase 1/2 · University of California, Irvine
Studies
Open first, then newest update. How each study uses Nelfinavir is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 82
- Nelfinavir, Cisplatin, and External Beam Radiation Therapy for the Treatment of Locally Advanced Vulvar Cancer That Cannot Be Removed by SurgeryRecruitingPhase 1M.D. Anderson Cancer CenterNCT04169763Written as Nelfinavir
- Treating Anemia in Myelofibrosis With Repurposed Drugs (Nelfinavir) That Restore Iron Delivery to the Bone MarrowRecruitingPhase 1/2University of California, IrvineNCT07281781Written as Nelfinavir
- COAST Therapy in Advanced Solid Tumors and Prostate CancerRecruitingPhase 1/2Medical University of South CarolinaNCT05036226Written as Hydroxychloroquine, Metformin, Sirolimus, Nelfinavir
- Autophagy Maintenance (AUTOMAIN)RecruitingPhase 2Medical University of South CarolinaNCT06971744Written as Nelfinavir
- Radiosensitizing Effect of Nelfinavir in Locally Advanced Carcinoma of CervixCompletedPhase 3Tata Memorial HospitalNCT03256916Written as Nelfinavir
- Nelfinavir Mesylate in Treating Patients With Kaposi SarcomaCompletedPhase 2AIDS Malignancy ConsortiumNCT03077451Written as Nelfinavir Mesylate
- Metformin, Nelfinavir, and Bortezomib in Treating Patients With Relapsed and/or Refractory Multiple MyelomaCompletedPhase 1Mayo ClinicNCT03829020Written as Nelfinavir Mesylate
- Systemic Therapy and Chemoradiation in Advanced Localised Pancreatic Cancer - 2CompletedPhase 1/2University of OxfordNCT02024009Written as Nelfinavir
- Stereotactic Radiation, Nelfinavir Mesylate & Neoadjuvant Chemotherapy in Locally Advanced Pancreatic CancerCompletedPhase 1University of NebraskaNCT01068327Written as nelfinavir mesylate
- Chemotherapy, Stereotactic Body Radiation Therapy & Nelfinavir Mesylate in Locally Advanced Pancreatic CancerCompletedPhase 2University of NebraskaNCT01959672Written as Nelfinavir Mesylate
- Phase II Trial of Nelfinavir With Concurrent Chemoradiotherapy in Squamous Cell Carcinoma of the Head and NeckCompletedPhase 2Abramson Cancer Center at Penn MedicineNCT02207439Written as Nelfinavir (Viracept®) 1250 mg
- Nelfinavir and Lenalidomide/Dexamethasone in Progressive Multiple MyelomaTerminatedPhase 1/2Swiss Group for Clinical Cancer ResearchNCT01555281Written as Nelfinavir
- Image Guided Hypofractionated Radiation Therapy, Nelfinavir Mesylate, Pembrolizumab, Nivolumab and Atezolizumab in Treating Patients With Advanced Melanoma, Lung, or Kidney CancerTerminatedPhase 2University of WashingtonNCT03050060Written as Nelfinavir Mesylate
- A Study of Several Anti-HIV Drug Combinations in HIV-Infected Patients Who Have Used IndinavirCompletedNot applicableNational Institute of Allergy and Infectious Diseases (NIAID)NCT00000892Written as Nelfinavir mesylate
- The Effectiveness of Nelfinavir and Efavirenz, Used Alone or Together, Combined With Other Anti-HIV Drugs in Patients Who Have Taken Anti-HIV DrugsCompletedPhase 2National Institute of Allergy and Infectious Diseases (NIAID)NCT00001087Written as Nelfinavir mesylate
- A Randomized Trial of the Efficacy and Safety of a Strategy of Starting With Nelfinavir Versus Ritonavir Added to Background Antiretroviral (AR) Nucleoside Therapy in HIV-Infected Individuals With CD4+ Cell Counts Less Than or Equal to 200/mm3CompletedNot applicableNational Institute of Allergy and Infectious Diseases (NIAID)NCT00000859Written as Nelfinavir mesylate
- A Study to Evaluate the Safety and Tolerance of Nelfinavir (NFV) Given With Zidovudine (ZDV) and Lamivudine (3TC) in HIV-Positive Pregnant Women and Their InfantsCompletedPhase 1National Institute of Allergy and Infectious Diseases (NIAID)NCT00000887Written as Nelfinavir mesylate
- Safety, Tolerability, and Anti-HIV Activity of DMP 266 (Efavirenz) in Combination With Nelfinavir in HIV-Positive ChildrenCompletedPhase 1National Institute of Allergy and Infectious Diseases (NIAID)NCT00000893Written as Nelfinavir mesylate
- The Effects of Staggered Dosing on Interactions Between Paired Combinations of Nelfinavir, Ritonavir, and SaquinavirCompletedNot applicableNational Institute of Allergy and Infectious Diseases (NIAID)NCT00000898Written as Nelfinavir mesylate
- Stereotactic Body Radiation With Nelfinavir for OligometastasesCompletedPhase 2Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsNCT01728779Written as Nelfinavir
See all 82 studies that test Nelfinavir →
Given beside what is tested · 3 — Nelfinavir is usual care or a partner of the new treatment
- Dose Escalation Study of Nelfinavir Plus MLN9708 in Patients With Advanced Solid Tumors or LymphomaWithdrawnPhase 1Dartmouth-Hitchcock Medical CenterNCT03422874Written as Nelfinavir
- Effect of Different Boosting Agents on Pharmacokinetics of BILR 355 BS Dissolved in Polyethylene Glycol 400 (PEG 400) in Healthy Male VolunteersCompletedPhase 1Boehringer IngelheimNCT02257008Written as Nelfinavir
- A Study to Determine Effective Prophylaxis and Treatment of Nelfinavir-Associated DiarrheaTerminatedPhase 3PfizerNCT00650637Written as nelfinavir
Codes
What other systems call Nelfinavir · ClinicalTrials.gg INT008735
- MeSH (NLM) D019888NelfinavirConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) HO3OGH5D7INELFINAVIRConfirmed FDA, NLM, Wikidata
- RxNorm 134527Confirmed FDA, Wikidata
- Wikidata Q423366nelfinavirConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C29285NelfinavirOne source FDA
- DrugBank DB00220One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D019888 | Nelfinavir | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | HO3OGH5D7I | NELFINAVIR | Confirmed FDA, NLM, Wikidata |
| RxNorm | 134527 | — | Confirmed FDA, Wikidata |
| Wikidata | Q423366 | nelfinavir | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C29285 | Nelfinavir | One source FDA |
| DrugBank | DB00220 | — | One source Wikidata |
Also registered as nelfinavir mesylate (UNII 98D603VP8V · RxNorm 266565).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.